Shilpa Medicare Limited — Important, 03-07-2026: Updates

Company incurred a 29.10 Cr provision for a Celltrion dispute and gained 37.00 Cr from a SAPL stake sale. It merged two subsidiaries and issued 1:1 bonus shares. A foreign associate's performance improved significantly, contributing 18.21 Cr profit, a turnaround from a 2.50 Cr loss.